Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.
J Neurosurg
; 114(3): 624-32, 2011 Mar.
Article
in En
| MEDLINE
| ID: mdl-20964595
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Blood-Brain Barrier
/
Angiogenesis Inhibitors
/
Glioma
/
Antibodies, Monoclonal
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurosurg
Year:
2011
Type:
Article
Affiliation country:
United States